Fiduciary Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
1,469
+122
+9% +$125K 0.2% 69
2026
Q1
$1.24M Buy
1,347
+522
+63% +$529K 0.16% 89
2025
Q4
$886K Buy
825
+6
+0.7% +$5.74K 0.13% 112
2025
Q3
$625K Sell
819
-30
-4% -$22.3K 0.1% 130
2025
Q2
$659K Buy
849
+61
+8% +$47.4K 0.12% 115
2025
Q1
$568K Buy
788
+1
+0.1% +$832 0.12% 112
2024
Q4
$630K Buy
787
+371
+89% +$307K 0.14% 100
2024
Q3
$380K Sell
416
-7
-2% -$6.29K 0.09% 154
2024
Q2
$398K Buy
+423
New +$338K 0.1% 129

Other funds holding LLY

Fiduciary Financial Group's LLY Position: Q2 2026 in Review

Fiduciary Financial Group increased its Eli Lilly (LLY) stake by 9.1% in Q2 2026, buying an estimated $125K and bringing the position to 1,469 shares worth $1.76M. The position accounts for 0.2% of the portfolio, ranked #69.

Fiduciary Financial Group first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fiduciary Financial Group held 1,469 shares of Eli Lilly worth $1.76M as of Q2 2026.
  • Fiduciary Financial Group bought 122 Eli Lilly shares in Q2 2026, an estimated $125K.
  • Eli Lilly made up 0.2% of Fiduciary Financial Group's portfolio in Q2 2026, its #69 holding.
  • Fiduciary Financial Group first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fiduciary Financial Group's 13F filing for Q2 2026, filed 10 Jul 2026.